NCT06696612

Brief Summary

Study types and frequency of nail changes in patients with vitiligocompared to healthy subjects

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2024

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

November 18, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 20, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

November 20, 2024

Status Verified

November 1, 2024

Enrollment Period

7 months

First QC Date

November 18, 2024

Last Update Submit

November 18, 2024

Conditions

VitiligoHealthy

Outcome Measures

Primary Outcomes (1)

  • Nail changes in Vitiligo

    Dermoscopic pictures of the nails

    At enrollment

Interventions

DermoscopyDIAGNOSTIC_TEST

Dermoscopic examination of the nails

Eligibility Criteria

Age12 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Vitiligo patients attending dermatology outpatient clinic of Assiut University Hospital

You may qualify if:

  • Age Adults patients 12-50 years old All types of vitiligo: Focal, generalized, acrofacial, segmental

You may not qualify if:

  • patients older than 50 (because of aging's nail changes Patients with autoimmune disorders Patients using systemic medication for any reason including oral contraceptive pill

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Vitiligo

Interventions

Dermoscopy

Condition Hierarchy (Ancestors)

HypopigmentationPigmentation DisordersSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Intravital MicroscopyMicroscopyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Central Study Contacts

Rehab S.A. Sotohy

CONTACT

+201000781890rehabsotohy@yahoo.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postgraduate student

Study Record Dates

First Submitted

November 18, 2024

First Posted

November 20, 2024

Study Start

November 1, 2024

Primary Completion

June 1, 2025

Study Completion

October 1, 2025

Last Updated

November 20, 2024

Record last verified: 2024-11